
April 26, 2019
Ode to Kai – Life in the Old Dog Yet
I am very happy that I have been allowed to reopen my practice and help people through a method I deeply care about.
Based on the guidelines of the BAG I have put in place the following safety measures for my practice. For the protection of us all, I ask you to read and observe these rules carefully.
Thus, even in these uncertain times, we create a safe place of well-being.
– If you have symptoms that indicate COVID-19 disease (cough, fever, respiratory problems, loss of sense of smell and taste) you may unfortunately NOT come to therapy. I advise you to contact a doctor and isolate yourself.
– Please do not come to the practice until shortly before the start of treatment to avoid long waiting times in waiting area.
– Please wash your hands thoroughly with soap after entering the practice. If necessary hand disinfectants are also available.
– In order to be able to guarantee the distance in the waiting area, we have reduced the number of chairs.
Magazines and children’s toys have been removed.
– We have to do without handshakes. We will have to make do with a smile.
– Since I cannot maintain the distance of 2m during body therapy, I will wear a hygiene mask during the hand-on part of the treatment. As a client you are not required to wear a mask, but I am happy for you to do so, if you so wish. For clients who belong to the At Risk Group (see appendix below), it is recommended that you do wear a hygiene mask.
– Thorough washing of hands before and after each treatment is a matter of course for me, as well as the extensive ventilation of the practice room during and after each session.
– Surfaces, door handles, light switches, water taps, WC flush buttons etc. will be disinfected several times a day.
I look forward to seeing you again and thank you very much for respecting and following of these rules.
Appointments can be made, as usual here: https://availabilitythisweek.as.me/
(English below)
–Anhang 61
(Art. 10b Abs. 3)
https://www.admin.ch/opc/de/classifiedcompilation/20200744/index.html#pp6ahref0
Kategorien besonders gefährdeter Personen
Note 6
(Article 10b(3))
Categories of particularly vulnerable persons
1. high blood pressure
– Arterial hypertension with end organ damage
– Therapy resistant arterial hypertension
2. cardiovascular diseases
2.1 General criteria
– Functional class NYHA ³ II and NT-Pro BNP > 125 pg/ml
– Patients with ³ 2 cardiovascular risk factors (one of them diabetes or arterial hypertension)
– Prior stroke and/or symptomatic vasculopathy
– Chronic renal failure (stage 3, GFR <60ml/min)
2.2 Other criteria
2.2.1 Coronary heart disease
– ACS (STEMI and NSTEMI) in the last 12 months
– Symptomatic chronic coronary syndrome despite medical therapy (independent from any previous revascularization)
2.2.2 Disease of the heart valves
– Native valve stenosis and/or regurgitation in addition to at least one general criterion
– Medium or severe stenosis and/or regurgitation
– Any surgical or percutaneous valve replacement
2.2.3 Heart failure
– Patient with functional class NYHA ³ II or NT-Pro BNP > 125pg/ml despite medical therapy of any LVEF (HFpEF, HFmrEF, HFrEF)
– cardiomyopathy of any cause
– Pulmonary arterial hypertension
2.2.4 Arrhythmia
– Any arrhythmia (bradycardia / tachycardia) in addition to a general criterion
– Atrial fibrillation
– Preliminary pacemaker insertion (incl. ICD and/or CRT implantation) in addition to a general
Criterion
– Prior ablation in addition to a general criterion
2.2.5 Adults with congenital heart disease
– Any congenital heart disease
3. chronic respiratory diseases
– Chronic Obstructive Pulmonary Diseases GOLD Stage II-IV
– Emphysema of the lungs
– Uncontrolled, especially severe bronchial asthma
– Interstitial lung diseases
– Active lung cancer
– Pulmonary Arterial Hypertension
– Pulmonary vascular disease
– Active Sarcoidosis
– Cystic Fibrosis
– Chronic lung infections (atypical mycobacterioses, bronchiectasis etc.)
– Ventilated patients
– Sleep apnoea in the presence of other risk factors (e.g. obesity)
4. diabetes
– Diabetes mellitus, with late complications or an HbA1c of > 8%.
5. diseases/therapies that weaken the immune system
– Severe immunosuppression (e.g. CD4+< 200μl)
– Neutropenia ≥1 Week
– Lymphocytopenia <0.2×109/L
– Hereditary immunodeficiencies
– Taking medication that suppresses the immune system (e.g. long-term use of of glucocorticoids, monoclonal antibodies, cytostatic drugs, etc.)
– Aggressive lymphomas (all entities)
– Acute lymphatic leukemia
– Acute Myeloid Leukemia
– Acute promyelocytic leukemia
– T-prolymphocytic leukemia
– Primary lymphomas of the central nervous system
– Stem cell transplantation
– Amyloidosis (light chain (AL)- amyloidosis)
– Aplastic anaemia under immunosuppressive therapy
– Chronic Lymphatisc
5. diseases/therapies that weaken the immune system
– Severe immunosuppression (e.g. CD4+< 200μl)
– Neutropenia ≥1 Week
– Lymphocytopenia <0.2×109/L
– Hereditary immunodeficiencies
– Taking medication that suppresses the immune system (e.g. long-term use of of glucocorticoids, monoclonal antibodies, cytostatic drugs, etc.)
– Aggressive lymphomas (all entities)
– Acute lymphatic leukemia
– Acute Myeloid Leukemia
– Acute promyelocytic leukemia
– T-prolymphocytic leukemia
– Primary lymphomas of the central nervous system
– Stem cell transplantation
– Amyloidosis (light chain (AL)- amyloidosis)
– Aplastic anaemia under immunosuppressive therapy
– Chronic Lymphatic Leukemia
– Asplenia / Splenectomy
– multiple myeloma
– Sickle cell disease
6. cancer
– Cancer under medical treatment
Translated with www.DeepL.com/Translator